"GREENWICH, Connecticut, June 8, 2017 /PRNewswire/ --
Provides range of discovery, CMC and non-clinical services
Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc (RGLS), an innovative biopharmaceutical company. The agreement includes a broad range of discovery and development services to support Regulus programs targeting microRNAs...."